Corticosteroid Injections in Podiatry: Indications, Technique, and Risks

Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

Corticosteroid injections are one of the most widely used interventional tools in podiatric medicine — providing targeted anti-inflammatory relief for a broad spectrum of foot and ankle conditions while avoiding the systemic effects of oral corticosteroids. When used appropriately — with precise diagnosis, correct anatomic targeting, and awareness of risks — they are safe and effective. When overused or imprecisely placed, they carry meaningful risks including soft-tissue atrophy, tendon rupture, skin depigmentation, and diabetic glucose dysregulation. Understanding the evidence base and technical requirements for each indication guides rational corticosteroid use.

Commonly Injected Conditions

Plantar fasciitis: the medial calcaneal tuberosity approach (placing the needle from the medial heel, directing it to the plantar fascia insertion under palpation or ultrasound guidance) provides reliable short-term pain relief in 60–80% of patients at 4–6 weeks. Long-term effect diminishes — corticosteroid injection for plantar fasciitis should be used as a bridge to orthotics and physical therapy, not as a stand-alone treatment. Risk of plantar fascia rupture (1–2%) limits injection frequency to maximum 1–2 per year per site. Morton’s neuroma: ultrasound-guided injection into the interdigital neuroma produces 70–80% short-term response; alcohol sclerosing series is preferred for sustained multi-treatment protocols. Retrocalcaneal bursitis: injection into the retrocalcaneal bursa (not the Achilles tendon) under ultrasound guidance rapidly reduces acute bursitis flares. First MTP joint (hallux rigidus and gout): intra-articular injection provides immediate gout flare relief and symptomatic improvement in hallux rigidus. MTP synovitis in RA: targeted periarticular or intra-articular injection under ultrasound guidance reduces synovial inflammation.

Ultrasound Guidance: When and Why

Real-time ultrasound guidance improves injection accuracy, particularly for small targets (interdigital neuromas, individual MTP joints, tendon sheaths), structures adjacent to tendons where blind injection risks intratendinous placement, and cystic structures requiring aspiration before injection. Ultrasound-guided plantar fascia injection reduces plantar fat pad injection rates (the primary cause of fat pad atrophy complications) by confirming needle placement at the fascia-bone interface rather than the plantar fat. Ultrasound-guided peroneal tendon sheath injection confirms peritendinous (not intratendinous) placement. For straightforward large joint or bursal injections (ankle, subtalar, retrocalcaneal bursa) with clear landmarks, ultrasound guidance adds incremental benefit but is not always required.

Corticosteroid Agents and Dosing

Common injectable corticosteroids in podiatry include: betamethasone (Celestone Soluspan) — long-acting crystalline suspension, 6 mg/mL, standard plantar fasciitis dose 1.5–3 mg; triamcinolone acetonide (Kenalog) — long-acting crystalline suspension, 10–40 mg/mL, most commonly used preparation in podiatry; and dexamethasone — soluble preparation appropriate for tendon sheath injection (less risk of crystalline deposit). Preparations are mixed with local anesthetic (1% lidocaine or 0.5% bupivacaine) to provide immediate post-injection comfort and confirm correct tissue placement by immediate pain relief.

Risks and Contraindications

Plantar fat pad atrophy — the most significant complication of plantar heel corticosteroid injection — results from corticosteroid-induced adipocyte lysis and fibroseptal disruption, reducing the mechanical cushioning of the plantar heel. Risk is dose-dependent and cumulative — limiting plantar heel injections to maximum 2–3 lifetime injections reduces risk. Skin depigmentation and subcutaneous atrophy occur when crystalline corticosteroid deposits near the skin surface — minimized by placing the injection at the intended deep target and not injecting during needle withdrawal. Achilles tendon rupture risk after intratendinous injection is significant — peritendinous injection under ultrasound guidance avoids this complication. Glucose dysregulation in diabetic patients can persist for 3–7 days after a corticosteroid injection — patients should monitor glucose and their prescribing physician should be aware.

Corticosteroid Injections at Balance Foot & Ankle

Dr. Biernacki at Balance Foot & Ankle performs ultrasound-guided corticosteroid injections for plantar fasciitis, Morton’s neuroma, retrocalcaneal bursitis, MTP synovitis, and other indicated foot and ankle conditions. Precise ultrasound guidance maximizes therapeutic effect while minimizing complications. Call (810) 206-1402 for a same-week evaluation and injection consultation.

Foot or Ankle Inflammation? Ask About Guided Injection Therapy.

Serving Southeast Michigan from Bloomfield Hills and Howell.

📞 (810) 206-1402 |

📧 Get Dr. Tom’s Free Lab Test Guide

Discover the 5 lab tests every person over 35 should ask their doctor about — explained in plain English by a board-certified physician.

Download Your Free Guide →

Book Online →

📍 Located in Michigan?

Our board-certified podiatrists treat this condition at two convenient locations. Same-day appointments often available.

Book Now →
(810) 206-1402

Injection Therapy Specialists in Michigan

Corticosteroid injections are a valuable tool in podiatric care when used appropriately. Our podiatrists follow evidence-based protocols for injection type, technique, and frequency.

Explore Our Treatment Options → | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Grice J, Marsland D, Smith G, Calder J. Efficacy of foot and ankle corticosteroid injections. Foot Ankle Int. 2017;38(1):8-13.
2. David JA, Sankarapandian V, Christopher PRH, Chatterjee A, Macaden AS. Injected corticosteroids for treating plantar heel pain in adults. Cochrane Database Syst Rev. 2017;(6):CD009348.
3. McMillan AM, Landorf KB, Gilheany MF, Bird AR, Morrow AD, Menz HB. Ultrasound guided corticosteroid injection for plantar fasciitis: randomised controlled trial. BMJ. 2012;344:e3260.